Weight loss attenuates microvascular decline in T2DM
Real-world study underlines importance of weight loss and glycaemic control
Modest weight loss in patients with type 2 diabetes could be the single greatest factor in arresting the decline in microvascular function, a UK study suggests.
The findings also show that patients prescribed sulfonylureas experience greater declines in microvascular function than those on other diabetes therapies, the researchers say.
